Physician profile
Nathan Moore
NPI 1295314268
$3,214.88
in general payments reported to CMS, 2019-2025
14 companies · $18.74 in 2025
The $18.74 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $318 · 2022: $1,671 · 2023: $519 · 2024: $688 · 2025: $18.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,226.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $1,212.64 | 2022 | |
| Integra Lifesciences Corporation | $519.41 | 2021-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $309.06 | 2022-2025 | Stravix, Renasys Go V2 Home |
| Horizon Therapeutics Plc | $260.16 | 2021-2022 | |
| Melinta Therapeutics, LLC | $183.14 | 2021-2022 | |
| Stryker Corporation | $182.38 | 2023-2024 | Invision, Infinity Adaptis, Inbone |
| Becton, Dickinson and Company | $118.77 | 2023 | Arista Ah Flexitip |
| Bioventus LLC | $105.31 | 2021-2024 | Exogen Ultrasound Bone Healing System |
| Kerecis Limited | $101.80 | 2022 | |
| Solventum Corporation | $84.76 | 2024 | Prevena, V.A.C. Dermatac, V.A.C. Veraflo Cleanse Choice |
| Abbvie INC. | $82.88 | 2023 | |
| Livanova USA, INC. | $20.95 | 2023 | Lifesparc |
| Organogenesis INC. | $18.84 | 2024 | |
| Convatec INC. | $14.78 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.